Dr. Xianting Ding is professor at School of Biomedical Engineering, deputy director of Institute for Personalized Medicine, Shanghai Jiao Tong University. He is elected into the Chinese Top Elite Researcher Program, Qiushi Foundation Elite Young Investigator, Southern California Scientist and Engineering Association Elite Young Researcher. He received his Ph.D. degree from Department of Mechanical Engineering at University of California, Los Angeles (UCLA). His research interests focus on developing Personalized Therapy and Precision Medicine, including: 1) developing bio-sensors for early detection of cancer, infectious disease, metabolic diseases, age-related diseases, cardiovascular diseases, based on cellular electrochemical, impedance, mechanical and photonic signaling; 2) developing personalized treatment; optimizing drug combinations; studying drug-drug interactions; building up models for bio-complex systems, based on Feedback System Control (FSC), Microfluidics and Bio-MEMS; 3) Traditional Chinese Medicine (TCM) modernization, extraction, purification, and re-combination for treating ischemia, osteoporosis and depression. He participated in the early investigation and development for 3 multi-million-USD international research centers, including Institute for Cell Mimetic Space Exploration (CMISE, funded by NASA), Center for Cell Control (CCC, funded by NIH) and Institute for Personalized Medicine (IPM, funded by Chinese Central Organization Department). He is now leading 16 international projects. He is on the editorial board member for Scientific Reports and SLAS Technology (JALA), the reviewer for 20 SCI journals, published 90 over peer reviewed journal papers and filed 30 national or international patents.